The stock of iShares DEX Short Term Bond Index Fund (TSE:XSB) hit a new 52-week low and has $26.14 target or 7.00% below today’s $28.11 share price. The 8 months bearish chart indicates high risk for the $2.35 billion company. The 1-year low was reported on Dec, 1 by Barchart.com. If the $26.14 price target is reached, the company will be worth $164.50 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 65,626 shares traded hands. iShares DEX Short Term Bond Index Fund (TSE:XSB) has declined 0.78% since April 27, 2016 and is downtrending. It has underperformed by 6.70% the S&P500.
More important recent iShares DEX Short Term Bond Index Fund (TSE:XSB) news were published by: Theglobeandmail.com which released: “Beware the risk in bond funds” on July 10, 2013, also Theglobeandmail.com published article titled: “Bond ETFs confuse you? Here’s a simple guide”, Theglobeandmail.com published: “How safe are short-term bond funds?” on August 30, 2013. More interesting news about iShares DEX Short Term Bond Index Fund (TSE:XSB) was released by: Theglobeandmail.com and their article: “Four tips for nervous bond investors” with publication date: June 14, 2013.
iShares DEX Short Term Bond Index Fund seeks to provide income by replicating, to the extent possible, the performance of the DEX Short Term Bond Index, net of expenses. The company has a market cap of $2.35 billion. The DEX Short Term Bond Index is a market capitalization weighted index consisting of a diversified range of investment grade federal, provincial, municipal and corporate bonds with a term to maturity between one and five years. It currently has negative earnings. XSB invests in sectors, such as federal, financial, provincial, energy and real estate.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.